Publications & Works

Publication Network
Articles 16
All (16)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (15)
Scopus (16)
TRDizin (1)

1. Serum Vitamin D Levels as a Prognostic Biomarker in Patients Receiving Immune Checkpoint Inhibitors

Şahi̇n T. K., BAŞ O., KAVGACI G., Güdük N., ŞİRVAN F., AKIN S., et al.
Journal of Oncological Science , vol.12, no.1, pp.1-8, 2026 (Scopus, TRDizin) Creative Commons License

2. Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis

Güzel H. G., Kıvrak Salim D., Kılıçkap S., Kemal Y., Akosman C., Köseoğlu Ç., et al.
Oncologist , vol.31, no.4, 2026 (SCI-Expanded, Scopus)

3. Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

Majidova N., Arak H., ÖZALP F. R., BAŞ O., ÖZÇELİK KÖKER G., Ozmarasali E. B., et al.
SCIENTIFIC REPORTS , vol.15, no.1, 2025 (SCI-Expanded, Scopus)

4. Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience

BAŞ O., Tokatli M., Guduk N., Erdogan D., Boyraz N. E., Cengelci C., et al.
JOURNAL OF CLINICAL MEDICINE , vol.14, no.8, 2025 (SCI-Expanded, Scopus)

5. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer

BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE , vol.14, no.5, 2025 (SCI-Expanded, Scopus)

6. Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors

BAŞ O., Tokatli M., Savkliyildiz M., Yazarkan Y., Guduk N., Kilinc C., et al.
EXPERT REVIEW OF ANTICANCER THERAPY , vol.25, no.4, pp.405-409, 2025 (SCI-Expanded, Scopus)

7. The association between HALP score and survival in patients treated with immune checkpoint inhibitors

ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY , vol.25, no.1, pp.81-89, 2025 (SCI-Expanded, Scopus)

8. Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma

Demir T., Araz M., Moloney C., Hendem E., Kocak M. Z., ERMAN M., et al.
CLINICAL LUNG CANCER , no.7, 2024 (SCI-Expanded, Scopus)

9. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

KUTLU Y., Dae S. A., YILMAZ F., Erdem D., Sendur M. A. N., Akbas S., et al.
CANCERS , vol.16, no.12, 2024 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

10. Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis

BAŞ O., Erul E., GÜVEN D. C., AKSOY S.
SUPPORTIVE CARE IN CANCER , vol.30, no.11, pp.9071-9078, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

11. Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.
FUTURE ONCOLOGY , vol.18, pp.323-331, 2022 (SCI-Expanded, Scopus) Sustainable Development

12. Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded, Scopus) Sustainable Development

13. Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

GÜVEN D. C., KILIÇKAP S., YILDIRIM H. Ç., Ceylan F., BAŞ O., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.5, pp.1281-1283, 2021 (SCI-Expanded, Scopus)

14. Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., Olgun P., et al.
CANCER RESEARCH , vol.81, no.4, 2021 (SCI-Expanded, Scopus) Sustainable Development

15. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma

BAŞ O., Ozbek A., Guven D., Aktepe O., KILIÇ L., KERTMEN N., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.5, pp.1230-1233, 2020 (SCI-Expanded, Scopus)

16. Classifying sarcopenia: using median value or cut-off values?

BAŞ O., DİZDAR Ö.
BREAST CANCER RESEARCH AND TREATMENT , vol.176, no.2, pp.479, 2019 (SCI-Expanded, Scopus) Creative Commons License
Papers Presented at Peer-Reviewed Scientific Conferences 2

1. Efficacy of systemic treatments in patients with metastatic lung invasive mucinous adenocarcinoma

Demir T., Araz M., Hendem E., Kocak M. Z., Erman M., Bas O., et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024, (Summary Text)

2. GEBELİK ESNASINDA ORTAYA ÇIKAN GİTELMANSENDROMU

BAŞ O., ÇALIK BAŞARAN N., KÜKNER S., ÖZIŞIK L., ÖZ Ş. G., ARICI M.
20. Ulusal iç Hastalıkları Kongresi, Antalya, Turkey, 10 - 14 October 2018, (Summary Text)
Metrics

Publication

18

Publication (WoS)

16

Publication (Scopus)

16

Citation (WoS)

8

H-Index (WoS)

1

Citation (Scopus)

4

H-Index (Scopus)

1

Project

1

Open Access

4
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING